--- title: "White papers - Avance Clinical" description: "Access our collection of whitepapers covering industry insights, research, and expert analysis." canonical: "https://www.avancecro.com/white-papers/" generated: "2026-09-21T10:09:28+00:00" --- # **White papers** [![Rethinking risk-based monitoring in early phase clinical trials](https://www.avancecro.com/wp-content/uploads/2026/08/AVA5599-Rethinking-Risk-Based-Monitoring-5-2-aspect-ratio-800-1000.jpg)](https://www.avancecro.com/white-papers/rethinking-risk-based-monitoring-in-early-phase-clinical-trials/) 21 August 2026 ### [Rethinking risk-based monitoring in early phase clinical trials](https://www.avancecro.com/white-papers/rethinking-risk-based-monitoring-in-early-phase-clinical-trials/) Discover how risk-based monitoring strategies like tSDV can improve early phase trial oversight without compromising data integrity. [Read more](https://www.avancecro.com/white-papers/rethinking-risk-based-monitoring-in-early-phase-clinical-trials/) [![The Biotech’s Case for Programmatic Oncology Development](https://www.avancecro.com/wp-content/uploads/2026/05/THE-BIOTECHS-CASE-FOR-PROGRAMMATIC-ONCOLOGY-DEVELOPMENT-scaled-aspect-ratio-800-1000.jpg)](https://www.avancecro.com/white-papers/the-biotechs-case-for-programmatic-oncology-development/) 15 May 2026 ### [The Biotech’s Case for Programmatic Oncology Development](https://www.avancecro.com/white-papers/the-biotechs-case-for-programmatic-oncology-development/) Discover how Avance Clinical’s Oncology Center of Excellence helps U.S. biotechs overcome early phase oncology challenges with expert strategy, faster startup, and global scalability. [Read more](https://www.avancecro.com/white-papers/the-biotechs-case-for-programmatic-oncology-development/)